We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Plaintiffs Point To "Tellabs" In Pfizer Securities Suit

Law360 (July 12, 2007, 12:00 AM EDT) -- The lead plaintiffs in a securities fraud lawsuit against Pfizer Inc. over the drug giant's decision to scrap its highly anticipated cholesterol drug torcetrapib moved to bolster their case Wednesday, arguing that a recent U.S. Supreme Court decision lends weight to their scienter allegations.

Attorneys with Schoengold Sporn Laitman & Lometti, P.C., the firm representing the plaintiffs in the case, said in court documents filed in the U.S. District Court for the Southern District of New York that the High Court's June 21 decision in Tellabs...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.